NOX2 protects against progressive lung injury and multiple organ dysfunction syndrome

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 307, Issue 1, 2014, Pages

  Whitmore, Laura C ^a,b   Goss, Kelli L ^a   Newell, Elizabeth A ^a   Hilkin, Brieanna M ^a   Hook, Jessica S ^a   Moreland, Jessica G ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Chronic granulomatous disease; Inflammation; MODS; SIRS

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM CULTURE; BONE MARROW CELL; CHRONIC GRANULOMATOUS DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; ENZYME DEFICIENCY; FLOW CYTOMETRY; GENOTYPE; HISTOLOGY; LUNG INJURY; LUNG LAVAGE; MACROPHAGE; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; MOUSE; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PERITONEUM CELL; PRIORITY JOURNAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WILD TYPE;

CHRONIC GRANULOMATOUS DISEASE; GP91PHOX; INFLAMMATION; MODS; SIRS;

ANIMALS; BONE MARROW CELLS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; LUNG; LUNG INJURY; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIPLE ORGAN FAILURE; NADPH OXIDASE; NEUTROPHIL INFILTRATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ZYMOSAN;

EID: 84903579751     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00054.2014     Document Type: Article

References (39)

1. Agusti AG, Togores B, Ibanez J, Raurich JM, Maimo A, Bergada J, Marse P, Jorda R. Effects of N-acetylcysteine on tissue oxygenation in patients with multiple organ failure and evidence of tissue hypoxia. Eur Respir J 10: 1962-1966, 1997.
2. Brown GD, Taylor PR, Reid DM, Willment JA, Williams DL, Martinez-Pomares L, Wong SY, Gordon S. Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med 196: 407-412, 2002.
3. Chandra R, Federici S, Nemeth ZH, Horvath B, Pacher P, Hasko G, Deitch EA, Spolarics Z. Female X-chromosome mosaicism for NOX2 deficiency presents unique inflammatory phenotype and improves outcome in polymicrobial sepsis. J Immunol 186: 6465-6473, 2011.
4. Chen EI. Mitochondrial dysfunction and cancer metastasis. J Bioenerg Biomembr 44: 619-622, 2012.
5. Copeland S, Warren HS, Lowry SF, Calvano SE, Remick D. Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol 12: 60-67, 2005.
6. Cummings CJ, Martin TR, Frevert CW, Quan JM, Wong VA, Mongovin SM, Hagen TR, Steinberg KP, Goodman RB. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J Immunol 162: 2341-2346, 1999.
7. Cuzzocrea S, Costantino G, Mazzon E, Caputi AP. Protective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the rat. Crit Care Med 27: 1524-1532, 1999.
8. Day BJ. Antioxidants as potential therapeutics for lung fibrosis. Antioxid Redox Signal 10: 355-370, 2008.
9. Flo TH, Halaas O, Torp S, Ryan L, Lien E, Dybdahl B, Sundan A, Espevik T. Differential expression of Toll-like receptor 2 in human cells. J Leukoc Biol 69: 474-481, 2001.
10. Galley HF, Howdle PD, Walker BE, Webster NR. The effects of intravenous antioxidants in patients with septic shock. Free Radic Biol Med 23: 768-774, 1997.
11. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and Tolllike receptor 2. J Exp Med 197: 1107-1117, 2003.
12. Gately MK, Carvajal DM, Connaughton SE, Gillessen S, Warrier RR, Kolinsky KD, Wilkinson VL, Dwyer CM, Higgins GF Jr, Podlaski FJ, Faherty DA, Familletti PC, Stern AS, Presky DH. Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo. Ann NY Acad Sci 795: 1-12, 1996.
13. Griffiths B, Anderson ID. Sepsis, SIRS and MODS. Surgery (Oxford) 27: 446-449, 2009.
14. Guo RF, Ward PA. Role of oxidants in lung injury during sepsis. Antioxid Redox Signal 9: 1991-2002, 2007.
15. Han W, Li H, Cai J, Gleaves LA, Polosukhin VV, Segal BH, Yull FE, Blackwell TS. NADPH oxidase limits lipopolysaccharide-induced lung inflammation and injury in mice through reduction-oxidation regulation of NF-kappaB activity. J Immunol 190: 4786-4794, 2013.
16. Holland SM. Chronic granulomatous disease. Clin Rev Allergy Immunol 38: 3-10, 2010.
17. Impellizzeri D, Mazzon E, Di Paola R, Paterniti I, Bramanti P, Cuzzocrea S. Effect of NADPH-oxidase inhibitors in the experimental model of zymosan-induced shock in mice. Free Radic Res 45: 820-834, 2011.
18. Kennedy AD, Willment JA, Dorward DW, Williams DL, Brown GD, DeLeo FR. Dectin-1 promotes fungicidal activity of human neutrophils. Eur J Immunol 37: 467-478, 2007.
19. Lamb FS, Hook JS, Hilkin BM, Huber JN, Volk AP, Moreland JG. Endotoxin priming of neutrophils requires endocytosis and NADPH oxidase-dependent endosomal reactive oxygen species. J Biol Chem 287: 12395-12404, 2012.
20. Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res 100: 460-473, 2007.
21. Matsuda N, Hattori Y. Systemic inflammatory response syndrome (SIRS): molecular pathophysiology and gene therapy. J Pharmacol Sci 101: 189-198, 2006.
22. Moreland JG, Davis AP, Matsuda JJ, Hook JS, Bailey G, Nauseef WM, Lamb FS. Endotoxin priming of neutrophils requires NADPH oxidase-generated oxidants and is regulated by the anion transporter ClC-3. J Biol Chem 282: 33958-33967, 2007.
23. Motoyama T, Okamoto K, Kukita I, Hamaguchi M, Kinoshita Y, Ogawa H. Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med 31: 1048-1052, 2003.
24. Ness TL, Hogaboam CM, Strieter RM, Kunkel SL. Immunomodulatory role of CXCR2 during experimental septic peritonitis. J Immunol 171: 3775-3784, 2003.
25. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, Aderem A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 97: 13766-13771, 2000.
26. Peake SL, Moran JL, Leppard PI. N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock. Crit Care Med 24: 1302-1310, 1996.
27. Pollock JD, Williams DA, Gifford MA, Li LL, Du X, Fisherman J, Orkin SH, Doerschuk CM, Dinauer MC. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 9: 202-209, 1995.
28. Rieber N, Hector A, Kuijpers T, Roos D, Hartl D. Current concepts of hyperinflammation in chronic granulomatous disease. Clin Dev Immunol 2012: 252460, 2012.
29. Robertson CM, Coopersmith CM. The systemic inflammatory response syndrome. Microbes Infect 8: 1382-1389, 2006.
30. Schappi MG, Jaquet V, Belli DC, Krause KH. Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase. Semin Immunopathol 30: 255-271, 2008.
31. Segal BH, Han W, Bushey JJ, Joo M, Bhatti Z, Feminella J, Dennis CG, Vethanayagam RR, Yull FE, Capitano M, Wallace PK, Minderman H, Christman JW, Sporn MB, Chan J, Vinh DC, Holland SM, Romani LR, Gaffen SL, Freeman ML, Blackwell TS. NADPH oxidase limits innate immune responses in the lungs in mice. PLoS One 5: e9631, 2010.
32. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122: 787-795, 2012.
33. Spies CD, Reinhart K, Witt I, Meier-Hellmann A, Hannemann L, Bredle DL, Schaffartzik W. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study. Crit Care Med 22: 1738-1746, 1994.
34. Touré F, Zahm JM, Garnotel R, Lambert E, Bonnet N, Schmidt AM, Vitry F, Chanard J, Gillery P, Rieu P. Receptor for advanced glycation end-products (RAGE) modulates neutrophil adhesion and migration on glycoxidated extracellular matrix. Biochem J 416: 255-261, 2008.
35. Volman TJ, Hendriks T, Goris RJ. Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome. Shock 23: 291-297, 2005.
36. Whitmore LC, Hilkin BM, Goss KL, Wahle EM, Colaizy TT, Boggiatto PM, Varga SM, Miller FJ, Moreland JG. NOX2 protects against prolonged inflammation, lung injury, and mortality following systemic insults. J Innate Immun 5: 565-580, 2013.
37. Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, Buckley RH, Foster CB, Chanock SJ, Dickler H. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79: 155-169, 2000.
38. Zhang WJ, Wei H, Frei B. Genetic deficiency of NADPH oxidase does not diminish, but rather enhances, LPS-induced acute inflammatory responses in vivo. Free Radic Biol Med 46: 791-798, 2009.
39. Zhang WJ, Wei H, Tien YT, Frei B. Genetic ablation of phagocytic NADPH oxidase in mice limits TNFalpha-induced inflammation in the lungs but not other tissues. Free Radic Biol Med 50: 1517-1525, 2011.